Změnit instituci
Pokročilé nano a mikrotechnologie Pokročilé materiály Strukturní biologie Gen. a prot. rostlin. systémů Molekulární medicína Výzkum mozku a lidské mysli Molekulární vet. medicína

ERA Chair - RNA a imunita - Mary O'Connell

Vedoucí výzkumné skupiny
Telefon: +420 54949 5460
E-mail:
Kancelář:

Mary group13

Research areas

  • Identification of novel RNA editing/RNA modification events in RNA
  • Investigating the biological function of nucleotide modification in innate immunity
  • Elucidating the role RNA modification in disease

Main objectives

  • To define the prevalence and biological function of RNA modification in RNA.
  • To establish in vitro systems whereby the level of different RNA modification can be altered so that the global consequences can be studied.
  • To determine if there are alterations in RNA modifications in autoimmune disorders.
  • To investigate if ADAR2 has a role in innate immunity in the brain.

Content of research

Innate immunity and inflammation are central to human health. This was stated succinctly by the Nobel Laureate David Baltimore in 2011: ‘Autoimmunity, cancer and metabolic diseases are all secondary to chronic inflammation. This places inflammation at the heart of modern medicine’. The ‘Damage Model’ of Polly Matzinger proposes that innate immunity does not response to pathogens but responds to danger as defined by cellular damage. Therefore different cellular stresses can cause cellular damage, accidently triggering innate immunity which manifests itself as an autoimmune disease.

For many years my group has studied ADARs that convert adenosine to inosine in dsRNA. In 2014 we were the first to demonstrate that inosine in cellular RNA allows the cell to discriminate between self and non-self RNAs. We showed that the Adar1-/-embryo is dead by day E12.5 as it lacks hematopoietic progenitor cells and has elevated interferon levels. However this mutant can be rescued by a mutation in Mavs-/- demonstrating that Adar1 is an essential component of the innate immune pathway.

There are over 140 different types of RNA modification so we propose that RNA modifications other that inosine play a role in the innate immune response. Therefore we want to isolate and identify different classes of RNAs (not tRNAs and rRNAs) which are enriched in RNA modification, investigate their biological functions if their levels change in autoimmune disorders.

seznam / vizitky

Mary Anne O'Connell

Mary Anne O'Connell, PhD.

vedoucí pracoviště
Liam Keegan

Liam Keegan, PhD.

senior researcher
Květoslava Brožinová

Ing. Květoslava Brožinová

odborná pracovnice
Dragana Vukić

Dragana Vukić, M.Sc.

odborná pracovnice - PhD student
Anzer Khan

Anzer Khan, M.Sc.

odborný pracovník - PhD student
Nagraj Sambrani

Nagraj Sambrani, PhD

odborný pracovník ve výzkumu - postdoc
Veronika Martínková

Mgr. Veronika Martínková

odborná pracovnice
Ketty Sinigaglia

Ketty Sinigaglia

odborná pracovnice - PhD student
Jiří Sedmík

Mgr. Jiří Sedmík

odborný pracovník - PhD student
Dagmara Marta Wiatrek-Moumoulidis

Dagmara Marta Wiatrek-Moumoulidis, PhD

odborná pracovnice ve výzkumu - postdoc
Petra Vrbická

Petra Vrbická

chovatelka laboratorních zvířat

VYBRANÉ PUBLIKACE

2017

  • GALLO, A; VUKIC, D; MICHALIK, D; O'CONNELL, MA; KEEGAN, LP, 2017:ADAR RNA editing in human disease; more to it than meets the I. HUMAN GENETICS 136 (9), p. 1265 - 1278.
  • KEEGAN, L; KHAN, A; VUKIC, D; O'CONNELL, M, 2017:ADAR RNA editing below the backbone. RNA 23 (9), p. 1317 - 1328.
  • QUIN, JE; BUJILA, I; CHERIF, M; SANOU, GS; QU, Y; HOMANN, MV; ROLICKA, A; SIRIMA, SB; O'CONNELL, MA; LENNARTSSON, A; TROYE-BLOMBERG, M; NEBIE, I; FARRANT, AKO, 2017:Major transcriptional changes observed in the Fulani, an ethnic group less susceptible to malaria. ELIFE 6

2015

  • M. A. O’CONNELL; N. MANNION; L.P. KEEGAN, 2015:The Epitranscriptome and Innate Immunity. PLoS Genetics 12 (11)
  • MANNION, N; ARIETI, F; GALLO, A; KEEGAN, LP; O'CONNELL, MA, 2015:New Insights into the Biological Role of Mammalian ADARs; the RNA Editing Proteins. BIOMOLECULES 5 (4), p. 2338 - 2362.

2014

  • MANNION, NM; GREENWOOD, SM; YOUNG, R; COX, S; BRINDLE, J; READ, D; NELLAKER, C; VESELY, C; PONTING, CP; MCLAUGHLIN, PJ; JANTSCH, MF; DORIN, J; ADAMS, IR; SCADDEN, ADJ; OHMAN, M; KEEGAN, LP; O'CONNELL, MA, 2014:The RNA-Editing Enzyme ADAR1 Controls Innate Immune Responses to RNA. CELL REPORTS 9 (4), p. 1482 - 1494.

2013

  • RAMASWAMI, G; ZHANG, R; PISKOL, R; KEEGAN, LP; DENG, P; O'CONNELL, MA; LI, JB, 2013:Identifying RNA editing sites using RNA sequencing data alone. NATURE METHODS 10 (2), p. 128 - 132.

2012

  • RICE, GI; KASHER, PR; FORTE, GMA; MANNION, NM; GREENWOOD, SM; SZYNKIEWICZ, M; DICKERSON, JE; BHASKAR, SS; ZAMPINI, M; BRIGGS, TA; JENKINSON, EM; BACINO, CA; BATTINI, R; BERTINI, E; BROGAN, PA; BRUETON, LA; CARPANELLI, M; DE LAET, C; DE LONLAY, P; DEL TORO, 2012:Mutations in ADAR1 cause Aicardi-Goutieres syndrome associated with a type I interferon signature. NATURE GENETICS 44 (11), p. 1243 - 1248.

2011

  • MARCUCCI, R; BRINDLE, J; PARO, S; CASADIO, A; HEMPEL, S; MORRICE, N; BISSO, A; KEEGAN, LP; DEL SAL, G; O'CONNELL, MA, 2011:Pin1 and WWP2 regulate GluR2 Q/R site RNA editing by ADAR2 with opposing effects. EMBO JOURNAL 30 (20), p. 4211 - 4222.

2010

  • GALEANO, F; LEROY, A; ROSSETTI, C; GROMOVA, I; GAUTIER, P; KEEGAN, LP; MASSIMI, L; DI ROCCO, C; O'CONNELL, MA; GALLO, A, 2010:Human BLCAP transcript: new editing events in normal and cancerous tissues. INTERNATIONAL JOURNAL OF CANCER 127 (1), p. 127 - 137.

2009

  • HEALE, BSE; KEEGAN, LP; MCGURK, L; MICHLEWSKI, G; BRINDLE, J; STANTON, CM; CACERES, JF; O'CONNELL, MA, 2009:Editing independent effects of ADARs on the miRNA/siRNA pathways. EMBO JOURNAL 28 (20), p. 3145 - 3156.
Přečtěte si také
Dr. Ondrej Hovorka: Models of magnetic nanoparticles for biomedical applications

29. ledna 2018 9:46

Dr. Ondrej Hovorka: Models of magnetic nanoparticles for biomedical…

LECTURE: Dr. Ondrej Hovorka: Models of magnetic nanoparticles for biomedical applications MONDAY, 5. 2. 2018 Seminar room C2.11, from …

Advanced Materials and Nanotechnology Seminar Series 2018: Dr Andriy Marko

25. ledna 2018 18:21

Advanced Materials and Nanotechnology Seminar Series 2018: Dr Andriy…

WHEN: 30. 01. 2018 WHERE: CEITEC BUT, Purkynova 123, large meeting room SPEAKER: Dr Andriy Marko TALK: Advances in PELDOR…